Clinical Application of Rapid Assay of Interleukin-6 in Influenza-Associated Encephalopathy

The characteristics of influenza-associated encephalopathy is the high mortality and nimble progress with coma which appears in general cases within 48 hours. Most of patients show no abnormalities in the standard blood checks on admission or in early stage. In this study we investigated if a rapid...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Mikage, Yamanaka, Gaku, Kawashima, Hisashi, Watanabe, Yoshiaki, Ioi, Hiroaki, Kashiwagi, Yasuyo, Takekuma, Kouji, Hoshika, Akinori, Hayakawa, Mizuho, Suzuki, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2005
Materias:
Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851426/
https://www.ncbi.nlm.nih.gov/pubmed/16403955
http://dx.doi.org/10.1155/2005/671609
Descripción
Sumario:The characteristics of influenza-associated encephalopathy is the high mortality and nimble progress with coma which appears in general cases within 48 hours. Most of patients show no abnormalities in the standard blood checks on admission or in early stage. In this study we investigated if a rapid assay of interleukin (IL)-6 is useful in influenza-associated encephalopathy in early stages. The levels of IL-6 in patients with influenza-associated encephalopathy did not show any significant difference compared with those in patients with febrile convulsion and rotavirus-associated convulsion. However the levels of IL-6 in severe cases were significantly higher than those of mild cases with influenza-associated encephalopathy. Consequently the rapid assay of serum IL-6 is useful to evaluate and decide the therapies.

Ejemplares similares